The Latest Cardiac and Vascular News
Elucid Founder, Andrew Buckler, To Present Findings at the SCCT Annual Scientific Meeting BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced today that its founder Andrew Buckler will present findings from two separate studies […]
The implant was performed at Duke University Hospital, one of the largest U.S. cardiology centers PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage […]
SAN FRANCISCO & PARIS–(BUSINESS WIRE)–Viz.ai, the world leader in AI-driven intelligent care coordination, has partnered with Avicenna.AI, a global leader in artificial intelligence solutions, to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. The collaboration will pave the way for faster […]
The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs BAAR, Switzerland and MOUNTAIN VIEW, Calif., July 14, 2021 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the successful treatment of […]
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX® arm compared to historically matched comparators Study halted early due to highly statistically significant reduction in 30-day heart failure-related costs observed during the prespecified interim analysis Company to host conference call and live webcast tomorrow, July […]
Novel 3-in-1 system provides predictable left atrium access to support transseptal interventions MIAMI, July 13, 2021 /PRNewswire/ — East End Medical, a private medical device company committed to improving catheter-based cardiac procedures, today announced it received U.S. Food and Drug Administration (FDA) clearance for the company’s SafeCross™ Transseptal Radiofrequency (RF) Puncture & Steerable Balloon […]
EurekaAI helps predict heart attacks through AI analysis of patient data LOS ALTOS, Calif., July 13, 2021 /PRNewswire/ — SymphonyAI, a leader in high-value enterprise AI solutions for key vertical sectors, announced today the expansion of a partnership with Semmelweis University Heart and Vascular Center, a leading research institution in East-Central Europe. […]
Highly specific HDAC6 inhibitors (HDAC6i) demonstrated improved cardiac function in mouse models of heart failure with preserved ejection in fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM) Potential utility of HDAC6 as a target in heart disease was validated using Tenaya’s Precision Medicine platform HDAC6i product candidate TYA-11631 is currently in IND-enabling […]
Patient’s own tissue naturally turn device into living heart valves and may reduce need for re-interventions EINDHOVEN, the Netherlands & ZURICH–(BUSINESS WIRE)–Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve. To […]
LAGUNA HILLS, Calif., July 6, 2021 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic VT. The two-hour mapping and ablation procedure was performed by Dr. Tom De Potter, MD, […]
